Back
Entrada Therapeutics Stock Predictions
7 Stocks to Consider Immediately (must-see chart)
See the green days for 7 major stocks right here, free of charge
Sell
42
TRDA
Entrada Therapeutics
Last Price:
$7.57
Seasonality Move:
15.76%
7 Day Trial
ALL ACCESS PASS
$
7
ALERT: Q3 Could Be a Pivotal Quarter for Nasdaq Stocks
Click Here to Download Your FREE Stock Report NowEntrada Therapeutics Stock Forecast
-
Over the next 52 weeks, Entrada Therapeutics has on average historically fallen by 9.5% based on the past 3 years of stock performance.
-
Entrada Therapeutics has fallen lower in 2 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
-
Is Entrada Therapeutics Stock Undervalued?The current Entrada Therapeutics [TRDA] share price is $7.16. The Score for TRDA is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
-
TRDA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Entrada Therapeutics Stock Go Up Next Year?
-
Over the next 52 weeks, Entrada Therapeutics has on average historically fallen by 9.5% based on the past 3 years of stock performance.
Entrada Therapeutics Stock Rating
Sell
42
Entrada Therapeutics (TRDA)
is a Sell
Is Entrada Therapeutics overpriced?
-
Entrada Therapeutics has fallen lower in 2 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
Entrada Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
entradatx.com
52-Week Data
52-Week High:
21.79
52-Week Low:
6.59
Prediction Charts
Market Cap:
271.7M
Price in USD:
7.16
Volume:
169.5K
Beta:
-0.11
Technical Analysis
SMA50:
7.90
SMA100:
9.07
SMA200:
12.89
52-Wk Change:
-52.74%
Stock Predictions
-
Is Entrada Therapeutics stock public?Yes, Entrada Therapeutics is a publicly traded company.
-
What is the Entrada Therapeutics stock quote today?The Entrada Therapeutics stock price is 7.16 USD today.
-
How to buy Entrada Therapeutics stock online?You can buy Entrada Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Jun-17 | 7.35 | 7.21 | 7.61 | 7.15 |
| Jun-18 | 7.20 | 7.03 | 7.41 | 6.94 |
| Jun-20 | 7.13 | 7.12 | 7.21 | 7.02 |
| Jun-23 | 7.08 | 7.04 | 7.19 | 6.94 |
| Jun-24 | 7.11 | 7.08 | 7.20 | 7.01 |
| Jun-25 | 7.07 | 7.06 | 7.19 | 6.93 |
| Jun-26 | 7.11 | 7.02 | 7.11 | 6.80 |
| Jun-27 | 7.03 | 6.91 | 7.08 | 6.83 |
| Jun-30 | 6.96 | 6.72 | 7.01 | 6.70 |
| Jul-1 | 6.69 | 7.11 | 7.28 | 6.59 |
| Jul-2 | 7.11 | 7.27 | 7.41 | 7.09 |
| Jul-3 | 7.30 | 7.23 | 7.38 | 7.13 |
| Jul-7 | 7.11 | 6.97 | 7.19 | 6.87 |
| Jul-8 | 7.01 | 7.16 | 7.27 | 7.01 |
Entrada Therapeutics Earnings
Entrada Therapeutics Earnings Report: Per Share Entrada Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Entrada Therapeutics Forecast Revenue Growth
Entrada Therapeutics Stock Analysis: Historical quarterly revenues per share for Entrada Therapeutics and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.30 per share, a decrease next quarter of $0.27 per share, a decrease this year of $4.26 per share, and a decrease next year of $0.98 per share.
* Entrada Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.